Atrys Health SA
MAD:ATRY
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.79
4.21
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Gross Margin
Atrys Health SA
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | ES |
| Market Cap | 248.3m EUR |
| Gross Margin |
67%
|
| Country | US |
| Market Cap | 91.8B USD |
| Gross Margin |
11%
|
| Country | US |
| Market Cap | 87.7B EUR |
| Gross Margin |
11%
|
| Country | US |
| Market Cap | 73B USD |
| Gross Margin |
14%
|
| Country | DE |
| Market Cap | 24.9B EUR |
| Gross Margin |
25%
|
| Country | US |
| Market Cap | 20.1B USD |
| Gross Margin |
28%
|
| Country | DE |
| Market Cap | 18.8B EUR |
| Gross Margin |
24%
|
| Country | US |
| Market Cap | 18.3B USD |
| Gross Margin |
33%
|
| Country | US |
| Market Cap | 13.7B USD |
| Gross Margin |
33%
|
| Country | DE |
| Market Cap | 12.4B EUR |
| Gross Margin |
25%
|
| Country | AU |
| Market Cap | 13.4B AUD |
| Gross Margin |
84%
|
Atrys Health SA
Glance View
Atrys Health SA is a biomedical company, which engages in the research and development of diagnostic services. The company is headquartered in Madrid, Madrid and currently employs 2,397 full-time employees. The company went IPO on 2016-07-22. The company operates under Atrys brand name. Atrys is a clinical and translational research laboratory dedicated to the diagnosis, prognosis and treatment of cancer, including hematologic and solid malignancies. The company has four areas of activity: Laboratory, Telemedicine, Radiotherapy, as well as Research and Development (R&D). The firm has its diagnostic laboratories and translational research in Barcelona and Granada, and offices in Madrid, Spain.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Atrys Health SA's most recent financial statements, the company has Gross Margin of 66.9%.
You don't have any saved screeners yet
